Patients with primary myelofibrosis: treatment and quality of life

Primary myelofibrosis (PMF) is one of the diseases that cannot be cured using modern methods of conservative therapy. Therefore, treatment aimed at reducing PMF severity and improving patient’s quality of life. In this article, a comparative analysis of treatment response and quality of life dependi...

Full description

Saved in:
Bibliographic Details
Published inOnkogematologii͡a Vol. 7; no. 2; pp. 6 - 13
Main Authors L. M. Meshcheryakova, O. V. Porotkova, L. G. Kovaleva, L. Yu. Kolosova
Format Journal Article
LanguageRussian
Published ABV-press 01.07.2014
Subjects
primary myelofibrosis
quality of life
treatment
Online AccessGet full text

Cover

More Information
Summary:Primary myelofibrosis (PMF) is one of the diseases that cannot be cured using modern methods of conservative therapy. Therefore, treatment aimed at reducing PMF severity and improving patient’s quality of life. In this article, a comparative analysis of treatment response and quality of life depending on therapy using was shown. Partial remission rate at approximately the same level after α-interferon treatment (55.3 %) and after cytotoxic drug (48.8 %) was observed. Significant improvement in quality of life during α-interferon treatment was revealed.
ISSN:1818-8346